SOURCE: BlueLithium

September 24, 2007 09:00 ET

BlueLithium Announces Major Pharmaceutical Initiative

Company's Performance Marketing Division Rolls Out Groundbreaking Solution to Power Clinical Trial Recruitment for Pharma Companies

SAN JOSE, CA--(Marketwire - September 24, 2007) - BlueLithium today announced a breakthrough solution to help pharmaceutical manufacturers overcome the challenges of recruiting patients for clinical trials. The solution is being launched in partnership with San Diego, CA-based morefocus group inc., a pioneering publisher of unbiased online health information and screening technologies. The new solution includes support for every stage of clinical trial recruitment: lead generation, screening and providing retention and research tools and metrics.

BlueLithium has the ability to reach 119 million users or 68 percent of the U.S. Internet population and drive them to high quality editorial content and screens addressing specific disease conditions and treatments provided by morefocus. This now enables pharmaceutical manufacturers to locate and meet their targets for qualified trial candidates in days or weeks, rather than months and years.

"Historically, finding subjects for clinical trial has been a lengthy, expensive process," said Jay Webster, general manager of BlueLithium's Performance Network. "This exclusive partnership between one of the largest US ad networks and one of the most respected publishers of quality online medical content is changing the paradigm."

Case studies have shown strong results for both new and rescue trials studies. A recent rescue campaign to recruit US patients for a low-incidence condition generated 49,000 online responses, identified 1,282 patients and qualified 202 study candidates, fully completing recruitment in just ten days. A second case study involved a Crohn's Disease trial already underway at 20 investigative sites in the U.S. Recruitment efforts were seriously behind schedule until the BlueLithium / morefocus solution was adopted. Within 12 weeks, enough qualified candidates for the condition were identified and directed to the study sites to complete the trial.

"The increasing cost and difficulty of completing recruitment in a timely fashion in the U.S. had moved an increasing percentage of clinical trials overseas," said Colin Lucas-Mudd, morefocus CEO. "However with over 85 percent of U.S. patients researching their condition online, it is now possible to reach, screen and recruit volunteers in North America with a proven Web-based recruitment solution. The ongoing compliance and persistency opportunities are an added, though very important, bonus."

The combination of BlueLithium's unparalleled reach and the morefocus content and screening platform, covering more than 100 conditions and orphan diseases, provides a unique opportunity for instant response outreach.

About BlueLithium:

Based in San Jose, CA, BlueLithium is the leading data driven performance marketing company, using data from 145 million consumers worldwide, sophisticated analytics and advanced ad targeting technologies to create value for both publishers and marketers. Founded in 2004, the company was named 2006 Innovator of the Year by AlwaysOn and has been named one of the top 100 private companies in America for three consecutive years. For more information, visit

About morefocus:

San Diego-based morefocus group's health networks reach, inform and engage consumers, patients, their caregivers and medical professionals. The Company applies its robust, HIPAA-compliant database and content aggregation Platform to shorten the clinical trial process, inform physicians, build brand awareness among potential patients, merge psychographic and demographic patient data and advance drug marketing to highly targeted audiences.

Contact Information

  • Media Contact:
    Morgan McDowell
    blast! PR for BlueLithium
    (919) 833-9975 x.12
    Email Contact